: 1 as of 31st December 2016 and 2017 respectively. Cash flow statement The cash flow statement as of 31st December 2017 and 2016 decreases 234.75 million THB or 39.71% from the previous year i.e. from
$819 million, up 33% YoY Earnings Per Share of THB 4.61, +16% YoY Operating Cash Flow of $1.0 billion 2019 Earnings Guidance reaffirmed Indorama Ventures 2018 MD&A 2 2018 Summary Financials Table 1
02-634-0135 www.interpharma.co.th 4. MP Financial Statement Balance Sheet (Unit : Baht) 2017 Audited Statement 2018 Audited Statement 2019 Audited Statement Assets Current Assets Cash and cash
+3.3% from retained earnings. Net debt to EBITDA (excluding lease liabilities and license payable) was 0.7x slightly decline compared to 4Q19. Cash flow (Post TFRS 9&16) In 1H20, Cash flow from operating
decrease in retained earnings. Cash flow For 9M21, cash flow from operation (after tax) was Bt64,699mn increasing +9.2%YoY on the back of EBITDA expansion. The investment to expand 5G/4G and fixed broadband
cash flow from operating activities. Since there are various calculation methods, its presentation may not be comparable to similarly titled measures used by other companies. (3) Comprises of total
the current circumstance, therefore has since adjusted the marketing strategy of the Company and the Subsidiary Company to focus tourism in Thailand in order to be able to reopen Phuket Fantasea on the
2017 Current Ratio (Times) 0.76 0.91 Interest-bearing Debt to Equity (Times) 2.09 1.13 LQSF Q4/2561 2560 Current Ratio (Times) 0.63 n.a. Interest-bearing Debt to Equity (Times) 0.80 n.a. Cash Flow (Unit
& Shareholders’ Equity Current assets have decreased largely due to reduced inventory predominantly fuel as it is used in production. Non-current assets have decreased in line with depreciation with no major
any other performance measure or as an alternative to cash flow from operating activities. Since there are various calculation methods, its presentation may not be comparable to similarly titled